# Lyrebird Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lyrebird-health

- Industry: Software
- Headquarters: Melbourne, Australia
- Website: www.lyrebirdhealth.com
- Total disclosed funding: $12M
- Latest round: Series A (May 25, 2025)
- Investors on record: 4

## About

Based in Melbourne, Australia, Lyrebird Health specializes in AI-driven medical scribing solutions designed to enhance healthcare documentation efficiency while ensuring patient confidentiality.Founded in 2023 in Melbourne, Australia, Lyrebird Health provides AI medical scribing services to healthcare professionals. The company has successfully completed 1 deal, raising USD 12.00 mn in a Series A round on May 25, 2025, co-led by Five V Capital and Octopus Investments, with support from StartMate and Horizon VC. The company is currently valued at USD 50.00 mn.Lyrebird Health specializes in providing an innovative AI medical scribe designed specifically for healthcare providers. This technology securely operates in the background during patient consultations, listening to conversations and generating clinical notes without compromising patient confidentiality. The core functionality of Lyrebird includes automating clinical documentation, creating referrals, summaries, certificates, and reports in a matter of seconds. The system learns from user interactions, adapting to individual documentation styles to enhance efficiency over time. The platform serves a diverse client base, including doctors, nurses, allied health professionals, and medical institutions across various regions, including Australia, the United States, and the United Kingdom. By integrating seamlessly with electronic medical records (EMR) systems, Lyrebird addresses the pressing need for streamlined documentation processes in healthcare environments.Lyrebird Health operates on a subscription-based revenue model, primarily targeting healthcare practitioners and organizations that require efficient documentation solutions. Clients engage with the platform through various pricing plans tailored to their specific needs, which include features such as personalized templates, smart editing, and dictation capabilities. The service empowers users to focus more on patient care by significantly reducing the time spent on administrative tasks. Transactions typically involve annual or monthly subscriptions, whereby clients pay for access to the platform, enabling them to utilize the AI scribe for their documentation needs.In May 2025, Lyrebird Health raised USD 12.00 mn in Series A funding to support technology development, enhance EMR integration, and expand into new markets. The funding will facilitate the launch of new products designed to advance their AI capabilities and improve user experience. The company is targeting expansion into additional regions including North America and Europe by late 2025.

## Funding rounds

- Series A, May 25, 2025, $12M — StartMate, Octopus Investments, Five V Capital, Horizon VC

## Investors

- StartMate (https://capitalatlas.ai/funds/startmate) — Series A
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A
- Five V Capital (https://capitalatlas.ai/funds/five-v-capital) — Series A
- Horizon VC (https://capitalatlas.ai/funds/horizon-vc) — Series A